IAVARONE, MASSIMO ALBERTO
IAVARONE, MASSIMO ALBERTO
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
We need evidence-based futility thresholds to transplant grade-3 acute on chronic liver failure patients with poor respiratory, haemodynamic, and metabolic parameters
2025 A.W. Avolio, M. Antonelli, L. Caccamo, F. Frongillo, L. Del Prete, A. Ferrarese, M. Iavarone, P. Burra
Pioneering applications of immunotherapy in the early stages of hepatocellular carcinoma
2024 E. Alimenti, L. Erica Nicola, N. Leonardo Antonio, M.A. Iavarone
Induced myocardial ischemia in candidates to liver transplantation without evidence of heart disease
2023 L. Mircoli, N. Bacà, B. Antonelli, L. Caccamo, E. Cattaneo, F. Colombo, C. Dibenedetto, L. Diehl, M.F. Donato, A. Faggiano, M.A. Iavarone, P. Lampertico, C. Marenghi, F. Polli, E. Quarenghi, F.B. Sozzi, C. Spaziani, G. Tosetti, C. Valsecchi, P. Vicardi, M. Vicenzi, A. Zefelippo, M. Ruscica, S. Carugo
Spike-specific humoral and cellular immune responses after COVID-19 mRNA vaccination in patients with cirrhosis: A prospective single center study
2023 M. Iavarone, G. Tosetti, F. Facchetti, M. Topa, J. Ming Er, S. Kit Hang, D. Licari, A. Lombardi, R. D'Ambrosio, E. Degasperi, A. Loglio, C. Oggioni, R. Perbellini, R. Caccia, A. Bandera, A. Gori, F. Ceriotti, L. Scudeller, A. Bertoletti, P. Lampertico
Clinical Impact of a Protocol Involving Cone-Beam CT (CBCT), Fusion Imaging and Ablation Volume Prediction in Percutaneous Image-Guided Microwave Ablation in Patients with Hepatocellular Carcinoma Unsuitable for Standard Ultrasound (US) Guidance
2023 P. Biondetti, A.M. Ierardi, E. Casiraghi, A. Caruso, P. Grillo, S. Carriero, C. Lanza, S.A. Angileri, A. Sangiovanni, M. Iavarone, G. Guzzardi, G. Carrafiello
Polymorphism AGT2 (rs4762) is involved in the development of dermatologic events: Proof-of-concept in hepatocellular carcinoma patients treated with sorafenib
2022 V. Sapena, M. Iavarone, L. Boix, F. Facchetti, M. Guarino, M. Sanduzzi Zamparelli, A. Granito, E. Samper, M. Scartozzi, J. Corominas, G. Marisi, A. Díaz, A. Casadei-Gardini, L. Gramantieri, P. Lampertico, F. Morisco, F. Torres, J. Bruix, M. Reig
Prothrombin induced by vitamin K absence or antagonist-II and alpha foetoprotein to predict development ofhepatocellular carcinoma in Caucasian patients with hepatitis C-related cirrhosis treated with direct-acting antiviral agents.
2022 E. Degasperi, R. Perbellini, R. D'Ambrosio, S.C. UCEDA RENTERIA, F. Ceriotti, A. Perego, C. Orsini, M. Borghi, M. Iavarone, M. Bruccoleri, A. Rimondi, A. De Silvestri, A. Sangiovanni, P. Lampertico
Incidence of liver- and non-liver-related outcomes in patients with HCV-cirrhosis after SVR
2022 R. D'Ambrosio, E. Degasperi, M. Anolli, I. Fanetti, M. Borghi, R. Soffredini, M. Iavarone, G. Tosetti, R. Perbellini, A. Sangiovanni, V. Sypsa, P. Lampertico
An unprecedented challenge: The north italian gastroenterologist response to COVID-19
2022 G.E. Tontini, G. Aldinio, N. Nandi, A. Rimondi, D. Consonni, M. Iavarone, P. Cantu, A. Sangiovanni, P. Lampertico, M. Vecchi
Real-Life Clinical Data of Lenvatinib versus Sorafenib for Unresectable Hepatocellular Carcinoma in Italy
2021 V. Burgio, M. Iavarone, G.G. Di Costanzo, F. Marra, S. Lonardi, E. Tamburini, F. Piscaglia, G. Masi, C. Celsa, F.G. Foschi, M. Silletta, D.C. Amoruso, M. Rimini, M. Bruccoleri, R. Tortora, C. Campani, C. Solda, M.G. Viola, A. Forgione, F. Conti, F. Salani, S. Catanese, C.M. Giacchetto, C. Fulgenzi, C. Coppola, P. Lampertico, A. Pellino, G. Rancatore, G. Cabibbo, F. Ratti, F. Pedica, A. Della Corte, M. Colombo, F. De Cobelli, L. Aldrighetti, S. Cascinu, A. Casadei-Gardini
Reshape and secure HCC managing during COVID-19 pandemic : A single centre analysis of four periods in 2020 versus 2019
2021 M. Iavarone, B. Antonelli, A.M. Ierardi, M. Topa, A. Sangiovanni, A. Gori, C. Oggioni, G. Rossi, G. Carrafiello, P. Lampertico
Interventional radiology image-guided locoregional therapies (Lrts) and immunotherapy for the treatment of hcc
2021 P. Biondetti, L. Saggiante, A.M. Ierardi, M. Iavarone, A. Sangiovanni, F. Pesapane, E.M. Fumarola, P. Lampertico, G. Carrafiello
The Interplay between Gut Microbiota and the Immune System in Liver Transplant Recipients and Its Role in Infections
2021 G. Ancona, L. Alagna, A. Lombardi, E. Palomba, V. Castelli, G. Renisi, D. Dondossola, M. Iavarone, A. Muscatello, A. Gori, A. Bandera
Congenital Hepatic Fibrosis as a Cause of Recurrent Cholangitis: A Case Report and Review of the Literature
2021 E. Palomba, M. Maggioni, G. Viero, D. Mangioni, R. Lombardi, B. Antonelli, D. Dondossola, M. Iavarone, A.L. Fracanzani, A. Bandera, A. Gori, A. Lombardi, E. Palomba, M. Maggioni, G. Viero, D. Mangioni, R. Lombardi, B. Antonelli, D. Dondossola, M. Iavarone, A.L. Fracanzani, A. Bandera, A. Gori, A. Lombardi
Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL) : a randomised, controlled, phase 2b/3 trial
2020 V. Mazzaferro, D. Citterio, S. Bhoori, M. Bongini, R. Miceli, L. De Carlis, M. Colledan, M. Salizzoni, R. Romagnoli, B. Antonelli, M. Vivarelli, G. Tisone, M. Rossi, S. Gruttadauria, S. Di Sandro, R. De Carlis, M.G. Luca, M. De Giorgio, S. Mirabella, L. Belli, S. Fagiuoli, S. Martini, M. Iavarone, G. Svegliati Baroni, M. Angelico, S. Ginanni Corradini, R. Volpes, L. Mariani, E. Regalia, M. Flores, M. Droz dit Busset, C. Sposito
Combination of CLIF-OF and CCI predicts survival in patients with cirrhosis and COVID-19
2020 M.A. Iavarone, R. D'Ambrosio, P. Lampertico
The combination of PIVKA-II and AFP improves the detection accuracy for HCC in HBV caucasian cirrhotics on long-term oral therapy
2020 A. Loglio, M. Iavarone, F. Facchetti, D. Di Paolo, R. Perbellini, G. Lunghi, F. Ceriotti, C. Galli, M.T. Sandri, M. Vigano, A. Sangiovanni, M. Colombo, P. Lampertico
Hepatic Fat-Genetic Risk Score Predicts Hepatocellular Carcinoma in Patients With Cirrhotic HCV Treated With DAAs
2020 E. Degasperi, E. Galmozzi, S. Pelusi, R. D'Ambrosio, R. Soffredini, M. Borghi, R. Perbellini, F. Facchetti, M. Iavarone, A. Sangiovanni, L. Valenti, P. Lampertico
Experience Wwith Early Sorafenib Treatment with Mtor Inhibitors in Hepatocellular Carcinoma Recurring after Liver Transplantation
2019 F. Invernizzi, M. Iavarone, C. Zavaglia, S. Mazza, U. Maggi, L. Cesarini, B.B. Antonelli, A. Airoldi, M.A. Manini, A. Sangiovanni, G. Rossi, M.F. Donato, L.S. Belli, P. Lampertico
TLL1 Variants do not predict hepatocellular carcinoma development in hcv cirrhotic patients treated with direct-acting antivirals
2019 E. Degasperi, E. Galmozzi, F. Facchetti, E. Farina, R. D'Ambrosio, R. Soffredini, M. Iavarone, P. Lampertico